Clinical Trials Logo
  1. Home
  2. Graves Disease
  3. NCT00697528
  4. Details
NCT00697528 Clinical Trial

Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy

Graves' Disease Clinical Trial

Official title:
Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00697528
Other study ID # 352/06
Secondary ID
Status Completed
Phase N/A
First received June 11, 2008
Last updated December 18, 2013
Start date January 2007
Est. completion date December 2008

Study information
Verified date June 2008
Source University of Sao Paulo
Contact n/a
Is FDA regulated No
Health authority Brazil: Ethics Committee
Study type Observational

Clinical Trial Summary

Orbital Venous flow study in patients with Grave's Orbitopathy in different manifestation forms and stages, made with Color Doppler Imaging

Description:

Prospective study with Grave's patients in active and fibrotic disease, myogenic and lipogenic forms, with muscle restriction and without muscle restriction and with or without optic compressive neuropathy. Blood flow was studied with Color Doppler Imaging (CDI) in the following orbital vessels:

- Superior Ophthalmic Vein (main target of the study protocol)

- Retinal Central Vein

- Retinal Central Artery

- Ophthalmic Artery

Recruitment information / eligibility
Status Completed
Enrollment 66
Est. completion date December 2008
Est. primary completion date December 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Clinical diagnosis of Grave's Orbitopathy with well defined disease.

Exclusion Criteria:

- Uncertain cases, with an undefined status of Grave's Ophthalmopathy.

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Brazil Hospital das Clínicas da Universidade São Paulo São Paulo

Sponsors (1)
Lead Sponsor Collaborator
University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

See also
  Status Clinical Trial Phase
Completed NCT01950260 - Early Levothyroxine Post Radioactive Iodine Phase 2/Phase 3
Completed NCT01269749 - Radioactive Iodide Therapy for Pediatric Graves' Disease Phase 2
Recruiting NCT06068179 - Graves' Disease Remission Study: MycoMeth Combo Phase 2/Phase 3
Recruiting NCT02114619 - Comparative Study of Different I-131 Doses in Graves' Disease N/A
Completed NCT04383795 - Change of Gut Microbiome in the Treatment of Graves' Disease
Completed NCT02384668 - D-vitamin And Graves' Disease; Morbidity And Relapse Reduction N/A
Completed NCT01885533 - Post-Radioiodine Graves' Management: The PRAGMA-Study N/A
Completed NCT01534169 - Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients Phase 1
Completed NCT00917241 - Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone Phase 4
Completed NCT00004660 - Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy N/A
Completed NCT02205801 - Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy N/A
Recruiting NCT02620085 - Thyroid Disease and Personality Study N/A
Completed NCT00958113 - Autoimmune Thyroid Disease Genetic Study N/A
Completed NCT02727738 - Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole N/A
Completed NCT00150124 - Block-replacement Therapy During Radioiodine Therapy Phase 4
Completed NCT03535090 - Coagulation After Intravenous Methylprednisolone Administration
Not yet recruiting NCT02373995 - Role of the Microbiome in Graves' Orbitopathy Phase 1/Phase 2
Completed NCT00505011 - Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves’ Disease N/A
Completed NCT02107794 - Shared Decision Making in Graves Disease - Graves Disease (GD) Choice N/A
Recruiting NCT01182584 - Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease N/A